Prevention of invasive aspergillosis in AIDS by sulfamethoxazole.
暂无分享,去创建一个
J. Meis | P. Verweij | J. Mouton | J. Afeltra
[1] W. El-Sadr,et al. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] David R. Holtgrave,et al. An overview of the 1999 US Public Health Service/Infectious Diseases Society of America guidelines for preventing opportunistic infections in human immunodeficiency virus-infected persons. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] D. Denning,et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.
[4] J. Rich,et al. Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: report of two cases. , 1998, Heart & lung : the journal of critical care.
[5] D. Armstrong,et al. Aspergillus species colonization and invasive disease in patients with AIDS. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.